ARS Pharmaceuticals
SPRY
#8299
Rank
NZ$0.54 B
Marketcap
NZ$5.41
Share price
-11.90%
Change (1 day)
-59.97%
Change (1 year)

P/S ratio for ARS Pharmaceuticals (SPRY)

P/S ratio as of November 2026 (TTM): 2.70

According to ARS Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 25.2. At the end of 2026 the company had a P/S ratio of 7.25.

P/S ratio history for ARS Pharmaceuticals from 2023 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20267.25-46.18%
202513.514.57%
202411.8-99.93%
2023> 1000